中文(繁體)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

cough/vomiting

鏈接已保存到剪貼板
頁 1 從 24 結果
FIELD OF THE INVENTION This invention is directed to the field of medical devices and testing and, more particularly, to apparatus and techniques for evaluating urinary stress incontinence. BACKGROUND OF THE INVENTION According to the American Academy of Family Physicians, urinary incontinence (UI)
FIELD OF THE INVENTION This invention is directed to the field of medical devices and testing and, more particularly, to apparatus and techniques for evaluating urinary stress incontinence. BACKGROUND OF THE INVENTION According to the American Academy of Family Physicians, urinary incontinence (UI)

Oral-esophageal-gastric device to diagnose reflux and/or emesis

只有註冊用戶可以翻譯文章
登陸註冊
FIELD OF THE INVENTION This invention is directed to the field of medical devices and testing and, more particularly, to apparatus and techniques for evaluating urinary stress incontinence. BACKGROUND OF THE INVENTION According to the American Academy of Family Physicians, urinary incontinence (UI)

Opioid compounds and methods for using same

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter

Opioid compounds

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter

Opioid compounds and methods for making therefor

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter
TECHNICAL FIELD The present invention relates generally to a method of modulating substance P by compounds containing calcium sulfate, particularly syngenite, gorgeyite and gypsum, and more specifically, to the synthesis of such compounds as well as their use to treat a variety of conditions

NK1 antagonists

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION The invention relates to antagonists of the neuropeptide neurokinin-1 (NK.sub.1 or NK-1) receptor. Tachykinins are peptide ligands for neurokinin receptors. Neurokinin receptors, such as NK.sub.1, NK.sub.2 and NK.sub.3, are involved in a variety of biological processes.

NK.sub.1 antagonists

只有註冊用戶可以翻譯文章
登陸註冊
BACKGROUND OF THE INVENTION This invention relates to antagonists of the neuropeptide neurokinin-1 (NK.sub.1 or NK-1) receptor, compositions containing the antagonists, and methods of using the antagonists for the treatment of various diseases and conditions, including emesis, depression, anxiety

NK.sub.1 antagonists

只有註冊用戶可以翻譯文章
登陸註冊
FIELD OF THE INVENTION The present invention relates to novel neurokinin-1 (NK.sub.1 or NK-1) receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds, to treat NK.sub.1 receptor mediated diseases and conditions, including, for

NK1 antagonists

只有註冊用戶可以翻譯文章
登陸註冊
FIELD OF THE INVENTION The present invention relates to novel neurokinin-1 (NK.sub.1 or NK-1) receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds, to treat NK.sub.1 receptor mediated diseases and conditions, including, for

Fused ring NK.sub.1 antagonists

只有註冊用戶可以翻譯文章
登陸註冊
FIELD OF THE INVENTION The present invention relates to novel neurokinin-1 (NK.sub.1 or NK-1) receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds, to treat NK.sub.1 receptor mediated diseases and conditions, including, for

NK1 antagonists

只有註冊用戶可以翻譯文章
登陸註冊
FIELD OF THE INVENTION The present invention relates to novel neurokinin-1 (NK.sub.1 or NK-1) receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds, to treat NK.sub.1 receptor mediated diseases and conditions, including, for

NK.sub.1 antagonists

只有註冊用戶可以翻譯文章
登陸註冊
FIELD OF THE INVENTION The present invention relates to novel neurokinin-1 (NK.sub.1 or NK-1) receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds, to treat NK.sub.1 receptor mediated diseases and conditions, including, for

Bridged ring NK.sub.1 antagonists

只有註冊用戶可以翻譯文章
登陸註冊
FIELD OF THE INVENTION The present invention relates to novel neurokinin-1 (NK.sub.1 or NK-1) receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds, to treat NK.sub.1 receptor mediated diseases and conditions, including, for
加入我們的臉書專頁

科學支持的最完整的草藥數據庫

  • 支持55種語言
  • 科學支持的草藥療法
  • 通過圖像識別草藥
  • 交互式GPS地圖-在位置標記草藥(即將推出)
  • 閱讀與您的搜索相關的科學出版物
  • 通過藥效搜索藥草
  • 組織您的興趣並及時了解新聞研究,臨床試驗和專利

輸入症狀或疾病,並閱讀可能有用的草藥,輸入草藥並查看其所針對的疾病和症狀。
*所有信息均基於已發表的科學研究

Google Play badgeApp Store badge